透明细胞肾癌中VHL基因通路的分子靶向治疗 - Suppr

Suppr

超能文献

Molecular targeting of VHL gene pathway in clear cell kidney cancer.

作者信息

Linehan W Marston

出版信息

J Urol. 2003 Aug;170(2 Pt 1):593-4. doi: 10.1097/01.ju.0000077210.05543.ae.

DOI:10.1097/01.ju.0000077210.05543.ae

PMID:12853837

Abstract

摘要

相似文献

Molecular targeting of VHL gene pathway in clear cell kidney cancer.

J Urol. 2003 Aug;170(2 Pt 1):593-4. doi: 10.1097/01.ju.0000077210.05543.ae.

Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.

J Urol. 2003 Aug;170(2 Pt 1):588-92. doi: 10.1097/01.ju.0000074870.54671.98.

Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.

Oncogene. 2000 Nov 16;19(48):5435-43. doi: 10.1038/sj.onc.1203938.

Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.

Cancer Res. 2003 May 15;63(10):2675-80.

Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.

Cancer Res. 2001 Jul 1;61(13):5215-22.

Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein.

Cancer Res. 1996 May 15;56(10):2299-301.

Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.

Cancer Res. 2001 Oct 1;61(19):7349-55.

Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.

Cancer Res. 2001 Apr 1;61(7):3206-11.

Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through hypoxia-inducible factor.

Oncogene. 2003 May 8;22(18):2728-38. doi: 10.1038/sj.onc.1206373.

Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma.

Cancer. 2002 Jul 1;95(1):47-53. doi: 10.1002/cncr.10635.

引用本文的文献

Biostatistics of VHL-Gene Transfection in the Health Informatics Analysis of Renal Cell Carcinoma.

Comput Math Methods Med. 2022 Jan 7;2022:5297580. doi: 10.1155/2022/5297580. eCollection 2022.

THSD7A expression: a novel immunohistochemical determinant in predicting overall survival of metastatic renal cell carcinoma treated with targeted therapy.

Ir J Med Sci. 2022 Aug;191(4):1561-1567. doi: 10.1007/s11845-021-02759-0. Epub 2021 Sep 1.

A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer.

Urol Oncol. 2021 Sep;39(9):548-560. doi: 10.1016/j.urolonc.2021.04.038. Epub 2021 Jun 4.

Von Hippel-Lindau Syndrome: Multi-Organ Involvement Highlighting Its Diverse Clinical Spectrum in Two Adult Cases.

Cureus. 2020 Jul 26;12(7):e9402. doi: 10.7759/cureus.9402.

TRIM8 anti-proliferative action against chemo-resistant renal cell carcinoma.

Oncotarget. 2014 Sep 15;5(17):7446-57. doi: 10.18632/oncotarget.2081.

Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients.

Tumour Biol. 2014 Oct;35(10):9839-45. doi: 10.1007/s13277-014-2194-4. Epub 2014 Jul 3.

Aerobic glycolysis: a novel target in kidney cancer.

Expert Rev Anticancer Ther. 2013 Jun;13(6):711-9. doi: 10.1586/era.13.57.

A tumor-specific gene therapy strategy targeting dysregulation of the VHL/HIF pathway in renal cell carcinomas.

Cancer Sci. 2005 May;96(5):288-94. doi: 10.1111/j.1349-7006.2005.00044.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验